Heyu Biological Technology Corporation (HYBT) financial statements (2021 and earlier)

Company profile

Business Address 4TH FLOOR, NO.10 BUILDING, XINGLIN BAY
XIAMEN CITY, FUJIAN PROVINCE, 361022
State of Incorp. NV
Fiscal Year End December 31
SIC 2833 - Medicinal Chemicals and Botanical Products (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9638  6091,9291,656
Cash and cash equivalents9638  6091,9291,656
Receivables8421  1,081338802
Inventory, net of allowances, customer advances and progress billings422   2023378
Inventory422   2023378
Prepaid expense48     
Prepaid expense and other current assets6
Other undisclosed current assets    577924
Total current assets:64959  1,7682,3692,865
Noncurrent Assets
Operating lease, right-of-use asset203
Property, plant and equipment    1491,781
Long-term investments and receivables      209
Long-term investments      209
Intangible assets, net (including goodwill)    1,9461,9461,946
Goodwill    1,9461,9461,946
Restricted cash and investments    300121508
Deferred costs    6130 
Other undisclosed noncurrent assets    552,672
Total noncurrent assets:203   2,3262,1117,116
TOTAL ASSETS:85259  4,0944,4809,981
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:111013 250243851
Accounts payable81   514881
Accrued liabilities31   149146633
Employee-related liabilities    504945
Taxes payable00    93
Other undisclosed accounts payable and accrued liabilities  13    
Deferred revenue431
Debt31   2526 
Due to related parties431 41    
Disposal group, including discontinued operation      95
Deferred revenue and credits  1696211
Other undisclosed current liabilities444296  (50)(49)(23)
Total current liabilities:1,44829654 394281934
Noncurrent Liabilities
Long-term debt and lease obligation173     1,167
Long-term debt, excluding current maturities      1,167
Operating lease, liability173
Total noncurrent liabilities:173     1,167
Total liabilities:1,62029654 3942812,100
Stockholders' equity
Stockholders' equity attributable to parent, including:(716)(237)(54) 3,7004,1997,881
Common stock1,0321,14115050505050
Additional paid in capital17,14917,14917,97018,07018,07018,07018,070
Accumulated other comprehensive income (loss)123(18,174)(18,119)   
Accumulated deficit(18,910)(18,421)  (14,419)(13,921)(10,238)
Other undisclosed stockholders' equity attributable to parent (109)     
Stockholders' equity attributable to noncontrolling interest(52)      
Total stockholders' equity:(768)(237)(54) 3,7004,1997,881
TOTAL LIABILITIES AND EQUITY:85259  4,0944,4809,981

Income statement (P&L) ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2014
12/31/2013
12/31/2012
Revenues164  1886,5781,6641,082
Revenue, net 1886,5781,6641,082
Cost of revenue(84)  (70)(4,857)(728)(223)
Cost of goods and services sold   (70)   
Gross profit:80  1181,722936860
Operating expenses(618)(248)(54)(406)(2,231)(1,673)(2,009)
Operating loss:(538)(248)(54)(288)(509)(737)(1,150)
Nonoperating income (expense)(2)  13011(449)(242)
Interest and debt expense   (1)   
Loss from continuing operations before equity method investments, income taxes:(540)(248)(54)(159)(499)(1,186)(1,392)
Loss from equity method investments     (211)(85)
Other undisclosed income from continuing operations before income taxes     21185
Loss from continuing operations before income taxes:(540)(248)(54)(159)(499)(1,186)(1,392)
Income tax benefit     93581
Loss from continuing operations:(540)(248)(54)(159)(499)(1,093)(811)
Loss from discontinued operations   (159)   
Loss before gain (loss) on sale of properties:(540)(248)(54)(317)(499)(1,093)(811)
Other undisclosed net income   159   
Net loss:(540)(248)(54)(159)(499)(1,093)(811)
Net income attributable to noncontrolling interest52      
Other undisclosed net loss attributable to parent     (2,589)(1)
Net loss available to common stockholders, diluted:(488)(248)(54)(159)(499)(3,682)(811)

Comprehensive Income ($ in thousands)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2014
12/31/2013
12/31/2012
Net loss:(540)(248)(54)(159)(499)(1,093)(811)
Other comprehensive income (loss)10(3)     
Other undisclosed comprehensive income52      
Comprehensive loss:(478)(250)(54)(159)(499)(1,093)(811)
Comprehensive loss, net of tax, attributable to noncontrolling interest(0)      
Comprehensive loss, net of tax, attributable to parent:(479)(250)(54)(159)(499)(1,093)(811)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: